Literature DB >> 1381397

Expression of CD7 on normal human myeloid progenitors.

C Chabannon1, P Wood, B Torok-Storb.   

Abstract

Existence of biphenotypic leukemias co-expressing CD7 and CD34 has prompted the question of whether a similar population of cells is present in normal human bone marrow. As CD7 is considered to be a T cell-restricted Ag, the co-expression of CD7 with the "human stem cell Ag" CD34 may identify a bipotent stage within hemopoietic differentiation. Cells with this phenotype have previously been isolated from human thymus. In this report we provide evidence that human marrow mononuclear cells also contain a minor subpopulation of cells co-expressing CD7 and CD34. The CD7+/CD34+ cells were found to contain committed myeloid progenitors assayed both as CFU in semi-solid media and by their ability to produce granulocytes in long term marrow cultures. Expression of CD7 on myeloid committed progenitors was further confirmed in a C-mediated cytotoxic assay. We conclude that CD7 expression is not restricted to T cells but is also expressed during early stages of myeloid differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381397

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Flow cytometric analysis of de novo acute myeloid leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group.

Authors:  Hideaki Ohta; Shotaro Iwamoto; Nobutaka Kiyokawa; Masahito Tsurusawa; Takao Deguchi; Kozo Takase; Junichiro Fujimoto; Keizo Horibe; Yoshihiro Komada
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

3.  Molecular cloning and expression analysis of pig CD7.

Authors:  Ju Yeon Lee; Joonbeom Bae; Inho Choi; Chung-Gyu Park; Taehoon Chun
Journal:  Vet Res Commun       Date:  2014-05-03       Impact factor: 2.459

4.  Murine CD7 shares antigenic cross-reactivity with HSP-60.

Authors:  Brandon A Howard; Gregory D Sempowski; Richard M Scearce; Hua-Xin Liao; David M Lee; Gordon K Lam; Haiyen Chen; Patrick Fadden; Timothy Haystead; Barton F Haynes
Journal:  Hybridoma (Larchmt)       Date:  2008-04

Review 5.  Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia.

Authors:  R Stasi; C G Taylor; A Venditti; G Del Poeta; G Aronica; C Bastianelli; M D Simone; F Buccisano; M C Cox; A Bruno
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

6.  Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes.

Authors:  G D Sempowski; D M Lee; R M Scearce; D D Patel; B F Haynes
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

7.  Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells.

Authors:  Jinle Tang; Jialu Li; Xuejun Zhu; Yuan Yu; Dan Chen; Lei Yuan; Zhenyang Gu; Xingding Zhang; Lin Qi; Zhishu Gong; Pengjun Jiang; Juhua Yu; Huimin Meng; Gangli An; Huyong Zheng; Lin Yang
Journal:  Oncotarget       Date:  2016-06-07

8.  Comparative Analysis of the Hematopoietic Progenitor Cells from Placenta, Cord Blood, and Fetal Liver, Based on Their Immunophenotype.

Authors:  Maria D Kuchma; Vitaliy M Kyryk; Hanna M Svitina; Yulia M Shablii; Lubov L Lukash; Galina S Lobyntseva; Volodymyr A Shablii
Journal:  Biomed Res Int       Date:  2015-08-05       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.